Apotex Health raised about C$1.3 billion in its Toronto market debut, marking the largest TSX IPO in five years. The Canadian generic drug manufacturer jumped on listing, signaling strong investor demand for the offering. The deal is a positive read-through for healthcare listings and broader Canadian IPO sentiment.
Apotex Health raised about C$1.3 billion in its Toronto market debut, marking the largest TSX IPO in five years. The Canadian generic drug manufacturer jumped on listing, signaling strong investor demand for the offering. The deal is a positive read-through for healthcare listings and broader Canadian IPO sentiment.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately positive
Sentiment Score
0.55
